Synergistic antibacterial activity of Curcumin with antibiotics against Staphylococcus aureus

Pakistan Journal of Pharmaceutical Sciences

Volumn 28, Issue 6, 2015, Pages 2109-2114

  Teow, Sin Yeang ^a   Ali, Syed Atif ^a  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

Author keywords

Antibacterial; Antibiotics; Curcumin; Staphylococcus aureus; Synergism

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; CURCUMIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; PLANT EXTRACT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; CONTROLLED STUDY; DISK DIFFUSION; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PHYTOTHERAPY; STAPHYLOCOCCUS AUREUS; TIME;

AMIKACIN; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; CURCUMIN; DISK DIFFUSION ANTIMICROBIAL TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENTAMICINS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 84947907792     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Clinical and Laboratory Standards Institute (2012). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-ninth edition: Approved standard. M07-A9., CLSI, Wayne, PA, USA, pp. 18-19.
2. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A and Nair GB (2009). Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother., 53: 1592-1597.
3. Goel A, Kunnumakkara AB and Aggarwal BB (2008). Curcumin as Curecumin: From kitchen to clinic. Biochem. Pharmacol., 75: 787-809.
4. Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK and Aggarwal BB (2011). Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep., 28: 1937-1955.
5. Kim MK, Park JC and Chong Y (2012). Aromatic hydroxyl group plays a critical role in antibacterial activity of the curcumin analogues. Nat. Pro. Comm., 7: 57-58.
6. Lin JK (2007). Molecular targets of curcumin. Adv. Exp. Med. Biol., 595: 227-243.
7. Moghaddam KM, Iranshahi M, Yazdi MC and Shahverdi AR (2009). The combination effect of curcumin with different antibiotics against Staphylococcus aureus. Int. J. Green Pharm., 3: 141-143.
8. Mun SH, Joung DK, Kim YS, Kang OH, Kim SB, Seo YS, Kim YC, Lee DS, Shin DW, Kweon KT and Kwon DY (2013). Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine, 20: 714-718.
9. Na HS, Cha MH, Oh DR, Cho CW, Rhee JH and Kim YR (2011). Protective mechanism of curcumin against Vibrio vulnificus infection. FEMS Immunol. Med. Microbiol., 63: 355-362.
10. Rai D, Singh JK, Roy N and Panda D (2008). Curcumin inhibits Fts Z assembly: An attractive mechanism for its antibacterial activity. Biochem. J., 410: 147-155.
11. Sharma M, Manoharlal R, Negi AS and Prasad R (2010). Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res., 10: 570-578.
12. Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV and Prasad R (2009). Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob. Agents Chemother., 53: 3256-3265.
13. Shen L and Ji HF (2012). The pharmacology of curcumin: Is it the degradation products? Trends Mol. Med., 18: 138-144.
14. Singh P and Panda D (2010). Fts Z inhibition: A promising approach for antistaphylococcal therapy. Drug News Perspect., 23: 295-304.
15. Teiten MH, Eifes S, Dicarto M and Diederich M (2010). Curcumin the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins., 2: 128-162.
16. Zhou H, Beevers CS and Huang S (2011). The targets of curcumin. Curr. Drug Targets, 12: 332-34.